- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rituximab (Rituxan)
Total 3338 results
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterWyeth is now a wholly owned subsidiary of PfizerCompletedAcute Lymphoblastic LeukemiaUnited States
-
SecuraBioWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingChildren | Blood Disease | Rituximab
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Georgetown UniversityGenentech, Inc.Terminated
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicArgentina, Venezuela
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Incyte CorporationCompletedB-cell LymphomaUnited States, Spain, Italy
-
Yale UniversityWithdrawnHematopoietic/Lymphoid Cancer | Infectious Mononucleosis | PTLD | Lymphoid Tumor | Plasmacytic Hyperplasia PTLD | Florid Follicular Hyperplasia PTLD | Polymorphic PTLD | Monomorphic PTLD | Classical Hodgkin Lymphoma Type PTLDUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Cyclacel Pharmaceuticals, Inc.Terminated
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaFrance, Germany, Austria
-
University of ArizonaWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Mediastinal Large B-cell Lymphoma | Grey Zone Lymphoma | High Grade B Cell LymphomaUnited States
-
Washington University School of MedicineAcerta Pharma BVActive, not recruitingMantle Cell LymphomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Hoffmann-La RocheTerminated
-
Nicole LamannaActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Aptevo TherapeuticsCompletedB-cell Small Lymphocytic Lymphoma RecurrentUnited States
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States
-
M.D. Anderson Cancer CenterCompleted
-
CephalonCompletedMantle Cell LymphomaUnited States, Canada
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States, Canada
-
Georgetown UniversityNational Cancer Institute (NCI)TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
University Hospital, ToulouseCompletedAutoimmune Diseases | Renal TransplantFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Seagen Inc.Genentech, Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States, France, Spain, Belgium, Australia, Germany, Poland, Italy, Czech Republic, Hungary
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
University of California, San FranciscoMillennium Pharmaceuticals, Inc.TerminatedB-cell Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
Mayo ClinicUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; University... and other collaboratorsCompletedIdiopathic Membranous NephropathyUnited States, Canada
-
Zhujiang HospitalUnknownRenal Insufficiency, Chronic | Nephrotic SyndromeChina
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
University of CopenhagenRigshospitalet, DenmarkCompletedFatigue | Keratoconjunctivitis Sicca | Primary Sjögren's Syndrome | Xerostomia | HyposalivationDenmark
-
M.D. Anderson Cancer CenterCompletedLymphomaUnited States
-
Massachusetts General HospitalGenentech, Inc.CompletedMicroscopic Polyangiitis | Granulomatosis With PolyangiitisUnited States
-
Steven P. Treon, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedLymphoplasmacytic Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Gruppo Italiano Terapie Innovative nei LinfomiCompletedDiffuse Large B-Cell LymphomaItaly
-
Ming HouPeking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaboratorsCompletedPurpura | Idiopathic Thrombocytopenic PurpuraChina
-
Shayna Sarosiek, MDAstraZenecaRecruitingWaldenstrom Macroglobulinemia | Neuropathy;Peripheral | IgM MGUSUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada, United States, Korea, Republic of, Australia, China, Taiwan, Spain, Italy, United Kingdom, Japan, Ireland, Denmark, Hungary, Poland, Czechia, France, Israel, Singapore, Belgium, Sweden, Germany, Switzerland
-
Deepa JagadeeshTerminatedPost-transplant Lymphoproliferative DisorderUnited States